Free Trial
NASDAQ:GLSI

Greenwich LifeSciences 5/22/2023 Earnings Report

Greenwich LifeSciences logo
$10.04 +0.06 (+0.60%)
Closing price 04/28/2025 04:00 PM Eastern
Extended Trading
$10.70 +0.66 (+6.57%)
As of 04:27 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Greenwich LifeSciences EPS Results

Actual EPS
-$0.17
Consensus EPS
-$0.23
Beat/Miss
Beat by +$0.06
One Year Ago EPS
N/A

Greenwich LifeSciences Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Greenwich LifeSciences Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Greenwich LifeSciences Earnings Headlines

HC Wainwright Issues Negative Outlook for GLSI Earnings
Here’s How to Claim Your Stake in Elon’s Private Company, xAI
Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.
See More Greenwich LifeSciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Greenwich LifeSciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Greenwich LifeSciences and other key companies, straight to your email.

About Greenwich LifeSciences

Greenwich LifeSciences (NASDAQ:GLSI), a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.

View Greenwich LifeSciences Profile

More Earnings Resources from MarketBeat